Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Intertek Expands Pharmaceutical Services
Intertek announced an expansion of the pharmaceutical services for specialist inhalation and nasal product development for biologics in Melbourne, near Cambridge
WuXi Biologics Announced Construction of a 69 million Integrated Manufacturing Center in Southwest China
WuXi Biologics commenced construction of a new 69 million integrated manufacturing centre for innovative biologics at Chengdu, Southwest China
Thermo Fisher Invests US$ 50 million to Expand Bioproduction Capabilities
Thermo Fisher Scientific announced that it is investing US$50 million in its global bioproduction capabilities
Intertek to Expand Pharmaceutical Services Facility in Melbourn
Intertek announced the expansion of its pharmaceutical services laboratory in Melbourn, near Cambridge, through the acquisition of a new 20,000 sq ft facility
Merck Announces Expansion of Manufacturing Facility with US$165 million investment
Merck announced an investment of US$165 million in its manufacturing site at Aubonne, Switzerland, to expand its production of biotech medicines
MaSTherCell SA Announces New Manufacturing Facility in Belgium
MaSTherCell SA announced new manufacturing facility in Belgium for cell and gene therapy products The company has signed a lease agreement for a 5,700m2 61,354ft facility located in Belgium The new facility will become a stateoftheart manufacturing and production site designed for latestage and commercially approved cell and gene therapy products
BioVectra Inc. Announces US$144.6 million Expansion
BioVectra Inc announced a fiveyear US$1446 million expansion project to enhance its Biopharmaceutical capabilities in Charlottetown, Prince Edward Island and Windsor, Nova Scotia
Merck Announces its Plans to Invest US$1.12 billion at the Darmstadt Site until 2025
Merck Group announced its plans to invest US$112 billion in its Darmstadt site until 2025 The aim of investing is to secure the future viability of company headquarters as a central science and technology hub and to further expand it
AveXis to Expand its Manufacturing Center in Durham County with US$ 60 million
AveXis is planning to expand its manufacturing center in Durham County, North Carolina, with an additional investment of US$60 million
Nanoform Announces Construction of GMP Manufacturing Plant to Provide API Solution
Introduction Nanoform announced the construction of a GMP manufacturing plant to provide API solution to particle nanonisation for clinical trials Features The company has signed a nineyear contract to build the 600m2 facility at Cultivator II in Viikki
